Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside
Authors
Keywords
-
Journal
Labmedicine
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-06-13
DOI
10.1093/labmed/lmaa049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment
- (2020) Jiajia Chen et al. Engineering
- From Hematologist’s desk: The effect of COVID ‐19 on the blood system
- (2020) Kamal Kant Sahu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Managing Sickle Cell Patients With COVID‐19 Infection: The Need to Pool Our Collective Experience
- (2020) Kamal Kant Sahu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
- (2020) Pietro Gentile et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID‐19
- (2020) Kamal Kant Sahu et al. JOURNAL OF MEDICAL VIROLOGY
- Latest updates on COVID‐2019: A changing paradigm shift
- (2020) Kamal Kant Sahu et al. JOURNAL OF MEDICAL VIROLOGY
- Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
- (2020) Christopher J. Rogers et al. Journal of Translational Medicine
- Cancer treatment during COVID-19 pandemic
- (2020) Vishal Jindal et al. MEDICAL ONCOLOGY
- Novel coronavirus 2019 (COVID-19)
- (2020) Steven Douedi et al. MEDICINE
- Stem Cell–Based Therapy for Coronavirus Disease 2019
- (2020) Robert Chunhua Zhao STEM CELLS AND DEVELOPMENT
- Mesenchymal stem cells as a potential therapy for COVID-19
- (2020) Shan Liu et al. Stem Cell Research & Therapy
- Cell‐based therapy to reduce mortality from COVID ‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
- (2020) Wenchun Qu et al. Stem Cells Translational Medicine
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- SARS-CoV-2 infection and stem cells: Interaction and intervention
- (2020) Fenggang Yu et al. Stem Cell Research
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
- (2019) Aleksandra Musiał-Wysocka et al. CELL TRANSPLANTATION
- Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges
- (2019) Christopher R. Nitkin et al. PEDIATRIC RESEARCH
- Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
- (2019) Andreas Robert Rudolf Weiss et al. Frontiers in Immunology
- Clarifying Stem-Cell Therapy’s Benefits and Risks
- (2017) Peter W. Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lung regeneration: mechanisms, applications and emerging stem cell populations
- (2014) Darrell N Kotton et al. NATURE MEDICINE
- Innate Immune Response of Human Alveolar Type II Cells Infected with Severe Acute Respiratory Syndrome–Coronavirus
- (2013) Zhaohui Qian et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IL-10-Dependent Regulatory Dendritic Cells by SOCS3 Activation
- (2012) X. Liu et al. JOURNAL OF IMMUNOLOGY
- Mesenchymal stem cells in tumor development
- (2012) Benjamin G. Cuiffo et al. Cell Adhesion & Migration
- Mesenchymal Stem Cells as Therapeutics
- (2010) Biju Parekkadan et al. Annual Review of Biomedical Engineering
- Tumor-Educated CD11b high Ia low Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
- (2009) Qiuyan Liu et al. JOURNAL OF IMMUNOLOGY
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population
- (2008) B. Zhang et al. BLOOD
- Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue
- (2008) C. K. Rebelatto et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells
- (2007) Eric C. Mossel et al. VIROLOGY
- SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium
- (2007) Amy C. Sims et al. VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started